The Covid-19 Cicada Variant is rapidly becoming a trending global health topic as scientists closely monitor its spread and behavior. Identified as BA.3.2, this new subvariant of the Omicron lineage has raised fresh concerns due to its unusually high number of mutations. But the big question remains — should India be worried about the Covid-19 Cicada Variant?
What Is the Covid-19 Cicada Variant?
The Covid-19 Cicada Variant (BA.3.2) is a newly identified subvariant of the Omicron family. It was first detected in South Africa in late 2024 and has since spread to over 20 countries, including significant presence in the United States.
According to the , the Covid-19 Cicada Variant has been classified as a “Variant Under Monitoring”, meaning experts are keeping a close watch on its transmission and mutation patterns.
What makes this variant stand out is its 70–75 mutations in the spike protein, which is significantly higher than earlier variants.
Why Is the Covid-19 Cicada Variant Trending?
The Covid-19 Cicada Variant is trending globally for several reasons:
- Rapid spread across 29 US states
- Detected in wastewater systems, indicating wider circulation
- High number of mutations compared to earlier strains
- Possible ability to evade immunity from past infections or vaccines
The has noted that these mutations may impact how the virus interacts with the human immune system.
Symptoms of the Covid-19 Cicada Variant
The symptoms of the Covid-19 Cicada Variant are largely similar to previous Omicron variants, making it harder to distinguish without testing.
Common Symptoms
- Sore throat
- Fever and chills
- Persistent cough
- Fatigue
- Headache
- Runny or blocked nose
Less Common Symptoms
- Nausea or vomiting
- Diarrhea
- Loss of taste or smell
Most cases linked to the Covid-19 Cicada Variant have been mild and manageable with standard care.
How Is It Different from Other Variants?
The biggest difference with the Covid-19 Cicada Variant is its mutation profile:
- 70–75 spike protein mutations (vs ~30 in original Omicron)
- Evolved from older BA.3 lineage
- May partially escape immunity
However, despite these changes, experts say there is no evidence yet that it causes more severe illness.
Is Vaccination Still Effective Against Covid-19 Cicada Variant?
Yes — vaccines still play a crucial role.
Even though the Covid-19 Cicada Variant may reduce some vaccine effectiveness against infection, vaccination continues to provide strong protection against severe illness, hospitalization, and death.
Health experts strongly recommend staying updated with booster doses if eligible.
Covid-19 Cicada Variant in India: Should You Be Worried?
Here’s the current situation:
- No significant surge in cases linked to the Covid-19 Cicada Variant in India
- Variant remains rare globally
- No evidence of increased severity
Experts and authorities are monitoring the situation closely, but there is no immediate cause for panic in India.
